trending Market Intelligence /marketintelligence/en/news-insights/trending/CFr-CTUU9a9UdTPIZcuifQ2 content esgSubNav
In This List

Nektar Therapeutics exec joins AntriaBio board

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Nektar Therapeutics exec joins AntriaBio board

AntriaBio Inc. added Gil Labrucherie to its board.

Labrucherie is senior vice president and CFO of Nektar Therapeutics.